188.50
2.25 (1.21%)
2.25 (1.21%)
Upgrade to Real-Time
Market Closed
Volume | 75 |
|
|||||
News | - | ||||||
Day High | 188.50 | Low High |
|||||
Day Low | 188.00 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Merck KGAA | MRK | Italy | Ordinary Share |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
188.00 | 188.00 | 188.50 | 188.50 | 186.25 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
2 | 75 | - | 155.00 - 231.40 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
06:41:57 | 25 | 188.50 € | EUR |
Merck KGAA News
Loading Messages....
Merck KGAA Discussion Forums - MRK
Date | Time | Comments | Title |
---|---|---|---|
8/03/2022 | 07:59 | - | Keytruda fails phase-3 in CRPC: |
6/22/2022 | 03:22 | - | FDA approves MRK’s pneumococcal vaccine, Vaxneuvance for infants/children: |
6/18/2022 | 16:17 | - | [color=red][i][b]WHAT ARE YOU TALKING ABOUT??? COVID-19 IS |
6/18/2022 | 15:31 | - | Pay attention, looks like we have a change |
6/07/2022 | 08:15 | - | MRK slides from ASCO webcast: |
5/26/2022 | 14:39 | - | Synopsis of (anti-LAG-3) favezelimab data from ASCO abstract: |
4/28/2022 | 04:54 | - | MRK 1Q22 results: |
4/25/2022 | 06:32 | - | CHMP approves Keytruda/chemo in the neoadjuvant setting followed |
4/14/2022 | 05:59 | - | MRK’s V116—(follow-on_to Vaxneuvance)—receives FDA BTD for prevention of |
4/01/2022 | 06:28 | - | MRK—Vaxneuvance sBLA for pediatrics gets 3-month extension to 7/1/22: |
Historical MRK Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 186.00 | 189.00 | 183.15 | 185.34 | 171 | 2.50 | 1.34% |
1 Month | 170.65 | 189.00 | 164.80 | 182.45 | 233 | 17.85 | 10.46% |
3 Months | 168.00 | 189.00 | 155.00 | 176.60 | 158 | 20.50 | 12.2% |
6 Months | 182.80 | 195.80 | 155.00 | 177.45 | 147 | 5.70 | 3.12% |
1 Year | 186.55 | 231.40 | 155.00 | 196.82 | 275 | 1.95 | 1.05% |
3 Years | 95.10 | 231.40 | 80.00 | 161.35 | 207 | 93.40 | 98.21% |
5 Years | 92.60 | 231.40 | 75.72 | 141.13 | 184 | 95.90 | 103.56% |
Dividends for Merck KGAA - Last 12 months
No dividends issued between Aug 11 2021 and Aug 11 2022